Iovance Biotherapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 300 | 0.0% | 109,997 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 250 | 0.0% | 115,038 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 186 | 0.0% | 107,959 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 735 | 0.0% | 220,759 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,679 | 0.0% | 226,834 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 1,631 | 0.0% | 173,655 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 1,896 | 0.0% | 236,369 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 2,361 | 0.0% | 159,280 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 1,298 | 0.0% | 159,698 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 755 | 0.0% | 165,860 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 1,164 | 0.0% | 165,344 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 653 | 0.0% | 106,822 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 760 | 0.0% | 118,862 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 1,208 | 0.0% | 126,107 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,480 | 0.0% | 134,038 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 1,882 | 0.0% | 113,039 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 342 | 0.0% | 17,909 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 455 | 0.0% | 18,463 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 451 | 0.0% | 17,342 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 553 | 0.0% | 17,475 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 822 | 0.0% | 17,720 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 608 | 0.0% | 18,470 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 488 | 0.0% | 17,780 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 5,412 | 0.0% | 180,800 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 4,747 | 0.0% | 171,500 | 12/31/2019 |